Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACON
Aclarion
$7.31
-0.2%
$7.13
$6.20
$3,499.51
$4.24M1.3458,424 shs10,142 shs
FRES
Fresh2 Group
$0.85
$0.96
$0.73
$3.40
$765K1.332,195 shsN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$252.25
-2.6%
$253.38
$198.96
$265.72
$21.13B0.82642,448 shs657,598 shs
Natera, Inc. stock logo
NTRA
Natera
$162.80
+0.6%
$160.74
$92.14
$183.00
$22.21B1.731.42 million shs486,688 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACON
Aclarion
-3.81%-2.59%+2.66%-14.69%-99.73%
FRES
Fresh2 Group
0.00%0.00%0.00%0.00%-72.68%
Labcorp Holdings Inc. stock logo
LH
Labcorp
+0.69%-0.22%+1.45%+18.54%+30.15%
Natera, Inc. stock logo
NTRA
Natera
+2.06%+0.11%-1.49%+12.89%+47.81%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aclarion, Inc. stock logo
ACON
Aclarion
2.2337 of 5 stars
3.03.00.00.02.30.01.3
FRES
Fresh2 Group
N/AN/AN/AN/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
4.454 of 5 stars
2.42.02.54.23.52.51.3
Natera, Inc. stock logo
NTRA
Natera
2.1423 of 5 stars
2.52.00.00.03.32.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aclarion, Inc. stock logo
ACON
Aclarion
2.00
Hold$11,758.50160,865.09% Upside
FRES
Fresh2 Group
4.00
Strong BuyN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.71
Moderate Buy$276.389.57% Upside
Natera, Inc. stock logo
NTRA
Natera
3.00
Buy$184.6313.41% Upside

Current Analyst Ratings Breakdown

Latest FRES, ACON, NTRA, and LH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$260.00
7/9/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$260.00 ➝ $285.00
6/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingCautious ➝ Cautious
6/25/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.00
6/11/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.00
5/30/2025
Aclarion, Inc. stock logo
ACON
Aclarion
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeModerate Buy
5/15/2025
Natera, Inc. stock logo
NTRA
Natera
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$205.00 ➝ $210.00
5/12/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$274.00 ➝ $290.00
5/9/2025
Natera, Inc. stock logo
NTRA
Natera
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$211.00 ➝ $218.00
5/9/2025
Natera, Inc. stock logo
NTRA
Natera
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$160.00 ➝ $190.00
5/6/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.00
(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aclarion, Inc. stock logo
ACON
Aclarion
$50K84.74N/AN/A$51.50 per share0.14
FRES
Fresh2 Group
$1.75M0.44N/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.01B1.62$21.95 per share11.49$96.27 per share2.62
Natera, Inc. stock logo
NTRA
Natera
$1.70B13.10N/AN/A$9.05 per share17.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aclarion, Inc. stock logo
ACON
Aclarion
-$6.99MN/A0.00N/AN/A-12,227.10%-126.89%-106.61%8/13/2025 (Estimated)
FRES
Fresh2 Group
-$14.77MN/A0.00N/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$746M$8.6529.1914.381.635.55%15.27%6.97%7/24/2025 (Estimated)
Natera, Inc. stock logo
NTRA
Natera
-$190.43M-$1.47N/AN/AN/A-10.36%-18.29%-11.68%8/14/2025 (Estimated)

Latest FRES, ACON, NTRA, and LH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2025Q2 2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.12N/AN/AN/A$3.49 billionN/A
5/15/2025Q1 2025
Aclarion, Inc. stock logo
ACON
Aclarion
-$1,447.20-$9.32+$1,437.88-$9.32$0.02 million$0.02 million
5/8/2025Q1 2025
Natera, Inc. stock logo
NTRA
Natera
-$0.59-$0.50+$0.09-$0.50$446.68 million$501.83 million
4/29/2025Q1 2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aclarion, Inc. stock logo
ACON
Aclarion
N/AN/AN/AN/AN/A
FRES
Fresh2 Group
N/AN/AN/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.881.14%N/A33.29%N/A
Natera, Inc. stock logo
NTRA
Natera
N/AN/AN/AN/AN/A

Latest FRES, ACON, NTRA, and LH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.721.11%8/28/20259/11/2025
4/10/2025
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.721.25%5/29/20256/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aclarion, Inc. stock logo
ACON
Aclarion
N/A
21.68
21.68
FRES
Fresh2 Group
N/AN/AN/A
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.68
1.84
1.60
Natera, Inc. stock logo
NTRA
Natera
N/A
3.87
3.74

Institutional Ownership

CompanyInstitutional Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
7.52%
FRES
Fresh2 Group
0.45%
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%
Natera, Inc. stock logo
NTRA
Natera
99.90%

Insider Ownership

CompanyInsider Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
0.77%
FRES
Fresh2 Group
26.22%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
Natera, Inc. stock logo
NTRA
Natera
7.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aclarion, Inc. stock logo
ACON
Aclarion
7580,000578,000Not Optionable
FRES
Fresh2 Group
75900,000663,000Not Optionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
70,00083.70 million83.00 millionOptionable
Natera, Inc. stock logo
NTRA
Natera
4,434136.55 million126.17 millionOptionable

Recent News About These Companies

Should You Invest in Natera (NTRA)?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aclarion stock logo

Aclarion NASDAQ:ACON

$7.30 -0.02 (-0.20%)
As of 02:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Fresh2 Group NASDAQ:FRES

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Labcorp stock logo

Labcorp NYSE:LH

$252.25 -6.82 (-2.63%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Natera stock logo

Natera NASDAQ:NTRA

$162.80 +1.05 (+0.65%)
As of 02:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.